... in the systemic glucocorticoid group. 51 NSAIDs Versus Selective COX-2 Inhibitors (COX-2) Three prior systematic reviews 47 , 51 , ... adverse events were observed among the recipients of selective COX-2 inhibitors (38 percent) versus recipients of NSAIDs (60 percent). ...

... treating osteoarthritis. [2008] 9.3. NSAIDs and highly selective COX-2 inhibitors 9.3.1. Clinical introduction Non-steroidal anti- ... are the relative benefits and harms of i) selective COX-2 inhibitors versus nonselective NSAIDs plus GI protective agents and ...

... explicitly referred to K.6. Non-specialist management – selective COX-2 inhibitors View in own window Reference Reason for exclusion ... 33-37 All participants had already tolerated a selective COX-2 inhibitor Di Leo E, Aloia AM, Nettis E, Cardinale ...

... for this review. J.6. Non-specialist management – selective COX-2 inhibitors J.6.1. Prognostic factor: history of asthmatic ... reaction Figure 12. Rate of drug reactions to selective COX-2 inhibitors by history of asthma exacerbated by NSAIDs versus ...

... selective NSAID should be recommended to take a selective COX-2 inhibitor (see Chapter 11 ). For those who have experienced ... GDG agreed that when NSAIDs are required and selective COX-2 inhibitors cannot be taken the quality of life gained ...

... the pooled estimates. The systematic review also found selective COX -2 inhibitors as a class associated with lower risk of ... dyspepsia, epigastric pain, and nausea compared with a selective COX -2 inhibitor alone, when each was compared to a nonselective ...

... and link to evidence 11. Non-specialist management Selective COX-2 inhibitors 11.1 Review question: In patients who have ... that indicate whether they can or cannot tolerate selective COX-2 inhibitors? 11.2 Clinical evidence 11.3 Economic evidence ...

... et al. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety ...

... 6103-5. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis. [J Med ... Thai. 2009] Gastrointestinal and cardiovascular risk of non-selective ... COX-2 inhibitors in elderly patients with knee osteoarthritis. Turajane T, ...

... 2 Topical treatments 9.3 NSAIDs and highly selective COX-2 inhibitors 10. Intra-articular Injections 10.1 Introduction 10. ...